The global Insulin Drugs Market size is expected to reach $60.15 billion in 2030 at a CAGR of 10.0%, driven by rising obesity rates.
Read More
The global Insulin Biosimilars Market size is expected to reach $6.89 billion in 2030 at a CAGR of 14.4%, driven by rising diabetes prevalence.
Read More
The global Insulin Aspart Market size is expected to reach $4.9 billion in 2030 at a CAGR of 6.3%, driven by rising diabetes prevalence.
Read More
The Insomnia Therapeutics Market size is expected to reach $4.19 billion in 2030 at a CAGR of 5.5%, driven by increasing stress and lifestyle changes.
Read More
The Inotropic Agents Market size is expected to reach $5.09 billion in 2030 at a CAGR of 12.6%, driven by rising cardiovascular disease prevalence.
Read More
The Injection Human Interleukin 2 Market size is expected to reach $1.96 billion in 2030 at a CAGR of 10.2%, driven by personalized medicine focus.
Read More
The Injectable Targeted Therapy Market size is expected to reach $105.2 billion in 2030 at a CAGR of 10.3%, driven by personalized medicine demand.
Read More
The Injectable Cytotoxic Drugs Market size is expected to reach $26.73 billion in 2030 at a CAGR of 6.5%, driven by rising rheumatoid arthritis cases.
Read More
The Inhaled Antibiotics Market size is expected to reach $2.54 billion in 2030 at a CAGR of 8.9%, driven by increasing hospital demand.
Read More
The Inhalation Sedatives Market size is expected to reach $3.26 billion in 2030 at a CAGR of 6.1%, driven by rising healthcare expenditure.
Read More